Works in Dermatology & Therapy, 2022, Vol 12, Issue 6

Results: 15

Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1469, doi. 10.1007/s13555-022-00747-5

By:

Okubo, Yukari;
Takahashi, Hidetoshi;
Hino, Ryosuke;
Endo, Koki;
Kikuchi, Satoru;
Ozeki, Yasushi;
Nakamura, Taichi;
Paris, Maria;
Abe, Masatoshi

Publication type:

Article

Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1289, doi. 10.1007/s13555-022-00746-6

By:

Menter, Alan;
Bhutani, Tina;
Ehst, Benjamin;
Elewski, Boni;
Jacobson, Abby

Publication type:

Article

The Tuberculosis Positive Conversion Rate Among Psoriasis Patients Treated with Adalimumab and Secukinumab: A Single-Center Retrospective Study in China.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1493, doi. 10.1007/s13555-022-00745-7

By:

Xiao, Yue;
Chen, Hui;
Zou, Qin;
Wang, Yiyi;
Gu, Yuanxia;
Wang, Jinqiu;
Yan, Wei;
Li, Wei

Publication type:

Article

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1447, doi. 10.1007/s13555-022-00744-8

By:

Teng, Lida;
Mizukami, Akiko;
Ng, Cheryl;
Giannelos, Nikolaos;
Curran, Desmond;
Sato, Tomohide;
Lee, Christa;
Matsuki, Taizo

Publication type:

Article

Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1431, doi. 10.1007/s13555-022-00743-9

By:

Griffiths, Christopher E. M.;
Gooderham, Melinda;
Colombel, Jean-Frederic;
Terui, Tadashi;
Accioly, Ana P.;
Gallo, Gaia;
Zhu, Danting;
Blauvelt, Andrew

Publication type:

Article

Baseline Demographics and Severity and Burden of Atopic Dermatitis in Adult Patients Initiating Dupilumab Treatment in a Real-World Registry (PROSE).

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1417, doi. 10.1007/s13555-022-00742-w

By:

Bagel, Jerry;
Nguyen, Tien Q.;
Lima, Hermenio;
Jain, Neal;
Pariser, David M.;
Hsu, Sylvia;
Yosipovitch, Gil;
Zhang, Haixin;
Chao, Jingdong;
Bansal, Shikha;
Chen, Zhen;
Richman, Daniel;
Korotzer, Andrew;
Ardeleanu, Marius

Publication type:

Article

Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1397, doi. 10.1007/s13555-022-00741-x

By:

Okubo, Yukari;
Umezawa, Yoshinori;
Sakurai, Shinya;
Hoshii, Naoki;
Nakagawa, Hidemi

Publication type:

Article

Utilization Trends and Impact of Secukinumab Treatment on Clinical Outcomes in Biologic-Naive Patients with Psoriasis in a US Real-World Setting.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1351, doi. 10.1007/s13555-022-00740-y

By:

Strober, Bruce;
Patil, Dhaval;
McLean, Robert R.;
Moore-Clingenpeel, Melissa;
Guo, Ning;
Levi, Eugenia;
Lebwohl, Mark

Publication type:

Article

Desire for Alternative Treatment Options in Patients with Atopic Dermatitis in Japan: Results of a Web-Based Cross-Sectional Study (AD-JOIN Study).

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1383, doi. 10.1007/s13555-022-00738-6

By:

Nakahara, Takeshi;
Takemoto, Shunya;
Houzawa, Hiroyuki;
Nakayama, Masahiko

Publication type:

Article

Symptom Experience and Content Validity of the Psoriasis Symptom Scale (PSS) in Patients with Generalized Pustular Psoriasis (GPP).

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1367, doi. 10.1007/s13555-022-00736-8

By:

Burden, A. David;
Mrowietz, Ulrich;
Skalicky, Anne M.;
Rentz, Anne M.;
Esser, Dirk;
Gloede, Tristan;
Thoma, Christian;
Menter, Alan

Publication type:

Article

Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1481, doi. 10.1007/s13555-022-00734-w

By:

de Bruin-Weller, Marjolein S.;
Serra-Baldrich, Esther;
Barbarot, Sebastien;
Grond, Susanne;
Schuster, Christopher;
Petto, Helmut;
Capron, Jean-Philippe;
Raibouaa, Afaf;
Werfel, Thomas

Publication type:

Article

Minimally Invasive Skin Transcriptome Extraction Using a Dermal Biomarker Patch.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1313, doi. 10.1007/s13555-022-00733-x

By:

Ibrahim, Sherrif F.;
Taft, Bradford J.;
Wang, Yipeng;
Lee, Byung-In;
Andrade, Eric;
Abaya, Christian;
Pramanick, Shreya;
Mannath, Thejus;
Hurley, Katherine A.;
Mahmood, Tahir A.;
Dickerson, Tobin J.

Publication type:

Article

Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1303, doi. 10.1007/s13555-022-00732-y

By:

Bellinato, Francesco;
Gisondi, Paolo;
Mason, Elena;
Ricci, Paolo;
Maurelli, Martina;
Girolomoni, Giampiero

Publication type:

Article

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1337, doi. 10.1007/s13555-022-00731-z

By:

Eichenfield, Lawrence F.;
Armstrong, April;
Guttman-Yassky, Emma;
Lio, Peter A.;
Chen, Chi-Chang;
Hines, Dionne M.;
McGuiness, Catherine B.;
Ganguli, Sohini;
Delevry, Dimittri;
Sierka, Debra;
Mallya, Usha G.

Publication type:

Article

Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 6, p. 1325, doi. 10.1007/s13555-022-00728-8

By:

Gulfan, Ma. Christina B.;
Wanitphakdeedecha, Rungsima;
Wongdama, Supisara;
Jantanapornchai, Nuttagarn;
Yan, Chadakan;
Rakchart, Sarawalai

Publication type:

Article